From a purely sporting point of view, and after suffering six confirmed positives in COVID-19 (tests were carried out only among those with symptoms, so there could even be some more), Espanyol could hardly compete on equal terms with most rivals, who have not suffered a similar setback (except Valencia and Alavés), since it is not only the time of convalescence, but the subsequent quarantine and, from there, having to resume training practically from scratch. Only time will discover which is the most reasonable solution or, failing that, which one is taken. Between coronaviruses and bombastic statements from the country’s alleged soccer leaders, the reality is that it is naturally unknown whether and when the competition will resume. A sea of doubts that catches even the Spanish, within which there is also a certain dichotomy about which outcome would be the most convenient.On the one hand are the offices, where they have no doubt that, from a financial point of view, what would satisfy is that LaLiga could be completed, since between 25 and 30 percent of the annual income already budgeted depend on it. Also by classification, since the permanence or the descent would be elucidated how it should be: on the playing fields. But that’s where this posture doesn’t exactly match the vision that emerges from the staff, which feels diminished in the current circumstances to have to face 11 decisive days for the future of the club.
Source:https://newsroom.wiley.com/press-release/british-journal-clinical-pharmacology/unnecessary-medicine-use-patients-lung-cancer-en Reviewed by James Ives, M.Psych. (Editor)Sep 6 2018Individuals with advanced lung cancer often have other comorbid conditions, and many may be on complex, costly, and even inappropriate medication regimens. A new British Journal of Clinical Pharmacology study examined the extent to which such patients are prescribed medications with questionable benefit.In an analysis of information from two centers in the United Kingdom and the United States, the use of preventative medicines–drugs for diabetes, hypertension, hyperlipidemia, antiplatelet agents, and vitamins/minerals–was common at hospital admission and discharge for patients who died of lung cancer.In the UK site (125 people), the average number of preventative medications was 1.9 at admission and 1.7 at discharge, whilst in the US site (191 people) the average was 2.6 at admission and 1.9 at discharge. “There may be scope to develop an intervention that embraces the principles of deprescribing at the point of hospital discharge to reduce inappropriate prescribing in lung cancer patients,” the authors wrote.